在 rhesus macaques 中,聚焦抗体对融合的反应
Christopher A Cottrell1,2, Payal P Pratap1,2, Kimberly M Cirelli3
1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
bioRxiv : the preprint server for biology
|July 10, 2023
概括
开发有效的艾滋病毒疫苗是具有挑战性的,因为抗体反应针对非中和部位. 这项研究使用了的持续免疫原递送来引起对保存的融合的反应,帮助未来的疫苗设计.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 结构生物学 结构生物学
背景情况:
- 开发有效的艾滋病毒疫苗面临挑战,包括抗体对非中和表位体的免疫主导性和广泛中和抗体 (bnAbs) 所需的广泛体质突变.
- 克服这些障碍需要创新的方法,如合理的蛋白质设计和非传统的免疫策略.
结论:
- 这项研究展示了一种新的免疫策略,使用持续输送免疫原来克服疫苗开发的挑战.
- 这些发现为下一代艾滋病毒疫苗设计提供了基础,专注于引起向抗体反应.
- 基于结构的疫苗设计可以通过了解通过先进的表位图绘制技术识别的关键残留物来推进.
更多相关视频
07:11Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques
Published on: April 22, 2010
21.2K
13:13Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
10.7K
相关概念视频
00:42Cross-reactivity
31.3K
Overview
31.3K
01:31Hybridoma Technology
15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K